The long noncoding RNA BC200 (brain cytoplasmic RNA, 200 nucleotides) acts as a translational modulator of local protein synthesis at dendrites. BC200 RNA has been shown to inhibit translation in vitro, but it remains unknown how this translation inhibition might be controlled in a cell. Here, we performed yeast three-hybrid screening and identified hnRNP E1 and hnRNP E2 as BC200 RNA-interacting proteins. We found that: these hnRNA proteins could restore BC200 RNA-inhibited translation; BC200 RNA interacts with hnRNP E1 and E2 mainly through its unique 3 0 C-rich domain; and the RNA binding specificities and modes of the two proteins differed somewhat. Our results offer new insights into the regulation of BC200 RNA-mediated translation inhibition.
The long noncoding RNA BC200 (brain cytoplasmic RNA, 200 nucleotides) acts as a translational modulator of local protein synthesis at dendrites. BC200 RNA has been shown to inhibit translation in vitro, but it remains unknown how this translation inhibition might be controlled in a cell. Here, we performed yeast three-hybrid screening and identified hnRNP E1 and hnRNP E2 as BC200 RNA-interacting proteins. We found that: these hnRNA proteins could restore BC200 RNA-inhibited translation; BC200 RNA interacts with hnRNP E1 and E2 mainly through its unique 3 0 C-rich domain; and the RNA binding specificities and modes of the two proteins differed somewhat. Our results offer new insights into the regulation of BC200 RNA-mediated translation inhibition.
Keywords: BC200 RNA; hnRNP E1; hnRNP E2; regulation of translation; RNA-protein interaction Long noncoding RNAs (lncRNAs) actively modulate eukaryotic gene expression by regulating chromatin states, transcriptional activity, and post-transcriptional events [1, 2] . Although translational control is considered to be one of the most important regulators of gene expression, only a few studies have characterized the roles of lncRNAs in the translation process [3] . The mouse Uchl1AS lncRNA, which is produced from the ubiquitin carboxyl-terminal esterase L1 (Uchl1) locus, was shown to activate the translation of the Uchl1 mRNA via a short interspersed nuclear element B2 repeat [4] . In yeast, an antisense KCS1 lncRNA represses translation of the mRNA for the inositol pyrophosphate synthase, KCS1 (which is expressed from the same locus), causing production of a truncated KCS1 protein [5] . In humans, the lncRNA, BC200 RNA (brain cytoplasmic RNA, 200 nts), negatively regulates translation in nerve cells [6, 7] . While Uchl1AS and KCS1 directly interact with their target mRNAs, BC200 RNA seems to have indirect effects on its target mRNAs. In vitro, BC200 RNA can inhibit translation by directly interacting with the eukaryotic translation initiation factors, eIF4A and eIF4B [8] [9] [10] . This interaction inhibits the helicase activity of eIF4A and the binding of eIF4B to the 18S rRNA. However, it remains poorly understood how BC200 RNA-mediated translation inhibition is regulated. Various BC200 RNA-interacting factors have been identified, including signal recognition particle (SRP) 9/14 [11] , poly(A)-binding protein (PABP) [12] , synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP) [13] , Pur-a [14] , and fragile X mental retardation protein (FMRP) [15] . Among them, only PABP is thought to be directly involved in Abbreviations EMSA, electrophoretic mobility shift assay; FMRP, fragile X mental retardation protein; IRES, internal ribosome entry site; KH, K homology; PABP, poly(A)-binding protein; SRP, signal recognition particle; SYNCRIP, synaptotagmin-binding cytoplasmic RNA-interacting protein; Uchl1, ubiquitin carboxyl-terminal esterase L1; X-gal, 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside.
regulating BC200 RNA-mediated translation inhibition. PABP, a component of the translational machinery, was shown to restore BC200 RNA-inhibited translation by binding the A-rich region of BC200 RNA [12] . However, it is possible that other protein groups beyond components of the translational machinery may participate in regulation of BC200 RNA-mediated translation inhibition by interacting with BC200 RNA.
Here, we set out to determine whether such regulatory proteins exist and, if so, how they might regulate BC200 RNA-mediated translation inhibition. We performed a yeast three-hybrid screening, and identified the heterogeneous nuclear ribonucleoproteins, hnRNP E1 and E2, as candidate binding proteins. The numerous members of the hnRNP family play important roles in mRNA maturation and/or the regulation of gene expression [16] . hnRNP E1, E2, and K are the principal proteins of the hnRNP E protein family, which is characterized by the presence of three K homology (KH) domains [17] . hnRNP E1 and E2, which share 82% similarity at the amino acid level and 93% similarity between their KH domains, have been extensively studied [18, 19] . There are many splice isoforms of hnRNP E2, whereas hnRNP E1 is expressed from an intronless gene that arose from the retrotransposition of a fully processed minor isoform of hnRNP E2 [20] . Although hnRNP E1 and E2 have been reported to participate in regulating mRNA stability, alternative splicing, transcription, and translation [21] [22] [23] Here, we show that hnRNP E1 and E2 interact with BC200 RNA, and that this interaction restores BC200 RNA-inhibited translation. Competing electrophoretic mobility shift assays (EMSAs) revealed that hnRNP E1 and E2 compete with eIF4A for binding to BC200 RNA. However, we observed that hnRNP E2, but not hnRNP E1, forms a ternary complex with BC200 RNA and eIF4A. Our footprinting analysis showed that binding of hnRNP E1, but not hnRNP E2, to BC200 RNA causes an alteration of the RNA secondary structure. Together, our results suggest that hnRNP E1 and E2 both control BC200 RNA-mediated translation inhibition, but that the two proteins may not act through the same control mechanism.
Materials and methods

Yeast three-hybrid analysis
A BC200-MS2 hybrid RNA construct was generated by inserting the BC200 RNA-encoding DNA into the AgeI and SmaI sites of the MS2 RNA fusion-plasmid vector, pRH3 0 (Invitrogen, Carlsbad, CA, USA), to generate pRH3 0 -BC200. The vector for expressing the LexA DNA-binding domain fused to the MS2 coat protein (pRS425/LexA-MS2) was a gift from Prof. J. Kim (Chungnam National University). The utilized human HeLa cDNA library had been previously prepared with the B42 trans-activating domain fusion-plasmid vector, pJG4-5 [33] . pRH3 0 -BC200, pRS425/ LexA-MS2, and the HeLa cDNA library were cotransformed into yeast strain L40-ura3 [34] using the LiOAc/single-strand carrier DNA/poly(ethylene glycol) method [34] . Yeast cells were grown in SD medium lacking histidine, tryptophan, leucine, and uracil. Clones expressing b-galactosidase activity were screened on plates using 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal) as a substrate. The primers used are listed in Table 1 .
Expression and purification of recombinant proteins
The DNA sequences encoding full-length hnRNP E1, hnRNP E2, or eIF4A were PCR amplified and cloned into the EcoRI and XhoI sites of the GST fusion vector, pGEX4T1 (GE Healthcare, Little Chalfont, UK). The resulting recombinant GST-fusion proteins were expressed in Escherichia coli and purified using glutathione affinity chromatography (Elpis Biotech, Daejeon, Korea) according to the manufacturer's protocol.
In vitro RNA preparation
The DNA templates for BC200 RNA [35] .
To prepare the DNA templates for luciferase mRNA, the luciferase expression plasmid DNA (Luciferase T7 Control DNA; Promega) was first mutagenized using a mutagenesis kit (Intron, Daejeon, Korea) to introduce SmaI and 
Electrophoretic mobility shift assay (EMSA)
All RNAs were denatured at 65°C for 5 min and renatured on ice for 10 min. Labeled RNAs (2 nM) were incubated with increasing amounts of proteins. For competition assays, unlabeled BC200 RNA or its domain variants were simultaneously added as competitors. 
In vitro translation
In vitro translation was performed using a TnT (transcription/translation)-coupled rabbit reticulocyte lysate system (L4610; Promega) or a standard rabbit reticulocyte lysate system (L4960; Promega). For the TnTcoupled rabbit reticulocyte lysate system, total reaction volumes of 10 lL containing the luciferase expression plasmid DNA (0.2 lg), cell lysate, [ 35 S] methionine, buffer, amino acids mixture minus methionine, RNase inhibitor (40 lÁlL À1 ), and increasing amounts of BC200
RNA were incubated for 90 min at 30°C according to the manufacturer's recommendations. When the standard rabbit reticulocyte lysate system was used, the luciferase expression plasmid DNA was replaced with luciferase mRNAs (0.5 lg). When required, proteins (GST, GSThnRNP E1, or GST-hnRNP E2) were added to the reaction mixtures before incubation. The reaction mixtures were separated by SDS/PAGE. All experiments were carried out at least twice using different batches of in vitrotranscribed RNAs and proteins. Gels were dried, placed on an imaging plate (BAS-IP; Fuji, Tokyo, Japan), and analyzed on a phospho-image analyzer (FLA-7000; GE healthcare). Protein bands were visualized and quantified using the IMAGE J software (NIH, Bethesda, MD, USA).
Semi-quantitative RT-PCR
RNAs were purified by phenol extraction from in vitro translation reactions. To remove any DNA, RNAs were RNA secondary structure mapping and footprinting assays
Labeled BC200 RNA was renatured by heating at 65°C for 5 min followed by incubation on ice for 10 min. For mapping of RNA secondary structure, RNA was digested with RNases (RNase T1, RNase A, and RNase V1) and Pb(II), as previously described [36] . For footprinting assays, RNA was preincubated with hnRNP E1 or E2 (50 and 200 nM, respectively) for 20 min at room temperature, and subjected to cleavage by RNases and Pb(II). The cleavage products were resolved on polyacrylamide-9 M urea sequencing gels and analyzed on a phospho-image analyzer (FLA-7000; Fuji).
Results
Identification of hnRNP E1 and E2 as BC200 RNAbinding proteins
To identify proteins that could regulate BC200 RNAmediated translation inhibition, we performed a yeast three-hybrid screen using BC200 RNA as the bait. Approximately 2 million clones from a human HeLa cell cDNA library were screened. We identified two clones each encoding hnRNP E1 and E2 as candidate binding proteins. GST-hnRNP E1 and E2 were expressed in E. coli and purified (Fig. S1) , and EMSAs were used to analyze their interactions with BC200 RNA. Our EMSA data indicated that hnRNP E1 and E2 bound to BC200 RNA with dissociation constants of 48.5 and 36.4 nM, respectively ( Fig. 1) , whereas GST did not interact with BC200 RNA (Fig. S2) . It is also noteworthy that the hnRNP E2-BC200 RNA complexes formed at 400 pmol of protein mostly appeared in multiple or smear bands near the well in this figure, but sometimes they were stuck in the well (see Fig. 3C ).
hnRNP E1 and hnRNP E2 restore BC200 RNAinhibited translation
Next, we set out to examine how the bindings of hnRNP E1 and E2 affect the functions of BC200 RNA. Since BC200 RNA negatively regulates the translation process [6, 8, 37] , we investigated the effects of hnRNP E1 and E2 on BC200 RNA-mediated translation inhibition in a rabbit reticulocyte lysate system. We found that BC200 RNA inhibited the translation of a reporter luciferase gene, and that this translation was substantially inhibited by 5 pmol of BC200 RNA (Fig. 2) . Therefore, we analyzed the effects of hnRNP E1 and E2 on translation in a coupled transcription/translation reticulocyte lysate system containing 6 pmol of BC200 RNA. When the luciferase expression plasmid DNA was used, we found that BC200 RNA-inhibited translation was restored by hnRNP E1 and E2. Even though the addition of high amounts (50 pmol) of hnRNP E1 or E2 inhibited translation in the absence of BC200 RNA, the rescue from BC200 RNA-mediated translation inhibition was the most effective at 50 pmol of hnRNP E1 or E2. These data indicate that hnRNP E1 and E2 can regulate the function of BC200 RNA. Since the coupled transcription/translation system utilized unmodified luciferase mRNAs generated from the reporter DNA, it is possible that the hnRNP E1-or E2-mediated rescue of the translation inhibition might be limited to the unmodified mRNA. Thus, we also performed in vitro translation assays using a coupled transcription/translation reticulocyte lysate system or a standard reticulocyte lysate system with in vitro-transcribed mRNAs bearing a 5 0 m 7 G-cap and/or a 3 0 poly (A) tail as well as bearing no modification (Figs. S3 and S4 ). When the coupled transcription/translation lysate system was used, mRNAs lacking the 5 0 m 7 G-cap were more efficiently translated than cap-bearing mRNAs. In the standard reticulocyte lysate system, on the other hand, translation of cap-bearing mRNAs was more efficient. In both systems, the lack of the poly (A) tail led to mildly reduced levels of translation. Despite the different translation efficiencies in two reticulocyte lysate systems, translation from all types of mRNAs was inhibited by BC200 RNA and the inhibition was rescued by hnRNP E1 and E2. These results suggest that the BC200 RNA-mediated translation inhibition and the rescue of this inhibition by hnRNP E1 or E2 occur in the rabbit reticulocyte lysate system regardless of the presence or absence of 5 0 and 3 0 mRNA modification.
However, one may argue that the rescue effects of hnRNP E1 or E2 on BC200 RNA-mediated translation inhibition could have been due to stabilization of the reporter mRNA by the proteins. However, we found that 50 pmol of hnRNP E1 or E2 alone inhibited translation even though the maximal rescue effects were observed at this high protein concentration. We also measured the remaining amounts of the reporter mRNA after the in vitro translation reactions and found that the mRNA amounts were almost the same regardless of the presence or absence of hnRNP E1 and E2 (Fig. S5) . Therefore, it seems likely that hnRNP E1 and E2 had no effect on stability of the reporter mRNA in our in vitro translation system. However, it remains to be demonstrated why translation is inhibited by high concentrations of hnRNP E1 or E2.
Domains of BC200 RNA required for the interactions with hnRNP E1 and E2
To delineate the binding domain(s) through which BC200 RNA interacts with hnRNP E1 and E2, we generated truncated domain derivatives of BC200 RNA. BC200 RNA can be dissected into three domains: a 5 0 Alu domain, a central A-rich domain, and a unique 3 0 C-rich domain [38] . We thus generated four domain derivatives: the Alu domain (nts: 1-121), the A/C-rich domain (nts: 122-200), the A-rich domain (nts: 122-161), and the C-rich domain (nts: 162-200). These derivatives were used to perform competitive EMSAs (Fig. 3) . Our data revealed that the A/C-rich and C-rich domains effectively competed with BC200 RNA for binding to both hnRNP E1 and E2. The Arich and Alu domains failed to show competition with BC200 RNA for binding to hnRNP E1, whereas they exhibited moderate competition for binding to hnRNP E2. These results suggest that both hnRNP E1 and E2 have binding specificity toward the C-rich domain of BC200 RNA, and that the binding specificity of hnRNP E1 is more strict than that of hnRNP E2.
hnRNP E1 and E2 compete with eIF4A for BC200 RNA binding
Since hnRNP E2 can bind to the A-rich domain, and this domain is known to be the target of eIF4A [8] [9] [10] , we hypothesized that hnRNA E2 might compete with eIF4A for BC200 RNA binding. We thus expressed GST-eIF4A proteins in E. coli, purified the proteins, and performed EMSAs. We found that eIF4A and BC200 RNA interacted with a K D of 1.27 lM (Fig. S6) . Next, we analyzed whether the interaction between eIF4A and BC200 RNA could be affected by increasing amounts of hnRNP E proteins (Fig. 4) . Surprisingly, both hnRNP E2 and hnRNP E1 competed with eIF4A for RNA binding. We speculate that the ability of hnRNP E proteins to compete with eIF4A might play an important role in their ability to restore BC200-inhibited translation. However, we found that hnRNP E1 and E2 had different competition patterns. hnRNP E2 exhibited an additional band with slightly slower mobility than the BC200RNA-hnRNP complex. The band is likely to be the eIF4A-BC200 RNA-hnRNP E2 ternary complex, suggesting that some BC200 RNA molecules can form the ternary complex.
Footprinting analysis of BC200 RNA-hnRNP E protein complexes
To explore a possible mechanistic basis for the differential binding of hnRNP E1 and E2 to BC200 RNA, we performed an RNA footprinting analysis using RNase V1, RNase A, RNase T1, and the Pb(II) ion. The cleavage patterns obtained in the absence of hnRNP E proteins agreed well with the predicted secondary structure [38] , except that nucleotides 130-132, 142, 143, 165, 166, and 176-181 in the A-rich and Crich domains were RNase V1 sensitive (Figs 5 and 6 ). Since RNase V1 cleaves both double-stranded and stacked single-stranded RNA regions, the RNase V1-protected regions in the A-rich and C-rich domains are likely to contain highly stacked structures. When we compared footprinting analyses carried out with hnRNP E1 versus E2 (Figs 7 and 8) , we observed that the protected regions were almost the same, including nucleotides 111, 119, 141, 148, and 174 as RNase Acleavage sites; nts 111, 112, 117, 130-132, 142, and 143 as RNase V1-cleavage sites; and nts 28-36, 69, 83-87, 120-122, and 140-179 as Pb(II)-cleavage sites. These data indicate that the protected regions span a broad region of BC200 RNA. This is consistent with the competitive EMSA data, which showed that hnRNP E proteins could compete for BC200 RNA with eIF4A, which binds to the A-rich region. Notably, the binding of hnRNP E1 increased the probe sensitivities of some sites, including: nucleotide 159 of the RNase A-cleavage sites; nucleotides 165, 166, 178, 180, and 181 of the RNase V1-cleavage sites; and nucleotides 70, 82, 123, and 145 of the Pb(II)-cleavage sites. hnRNP E2 binding did not significantly affect cleavage at these sites. This suggests that the binding of hnRNP E1 induces a structural change in BC200 RNA, increasing the exposure of certain regions (e.g., nucleotides: 70, 82 and 165-180) to cleavage. P-labeled BC200 RNA (10 nM) was partially digested with Pb(II) (25 mM), RNase V1 (0.1 U; V1), RNase T1 (1 U; T1), or RNase A (0.01 U; A). Untreated labeled BC200 RNA was used as a control and is indicated by C. RNase T1 and alkaline ladders are indicated by T1 and OH, respectively. Cleavage products were resolved on a 5% sequencing gel. Nucleotides that participate in forming the predicted pseudoknot are highlighted in red. This structural model was adapted from previous studies [47, 49] . The RNase V1 cleavage sites are also highlighted.
Discussion
BC200 RNA regulates RNA in neural cells by modulating local translation in the postsynaptic dendritic microdomain, and is also expressed at high levels in specific tumors and cancer cell lines. Studies have shown that BC200 RNA is closely related to proliferation and cell death [39] [40] [41] [42] . It is known to inhibit translation in vitro and in vivo [6, 8, 37] by interacting with components of the translational machinery, such as eIF4A, eIF4B, and PABP [6, 9] , but we know relatively little about how this process is regulated. In the present study, we identified hnRNP E1 and E2 as BC200 RNAinteracting proteins using a yeast three-hybrid screening. Our further studies revealed that hnRNP E1 and E2 bind BC200 RNA mainly through the unique 3 0 C-rich domain of BC200 RNA, and that these hnRNPs can restore BC200 RNA-inhibited translation inhibition.
hnRNP E1 and E2 (also known as PCBP1 and PCBP2) are ubiquitously expressed poly C-binding proteins. They each contain three KH domains, which are known to interact in a sequence-specific manner with C-rich motifs of RNA or DNA [43] . hnRNP E1 and E2 are involved in almost every step of gene regulation, from transcription to translation [24] . Although we found that both proteins could restore BC200 RNA-inhibited translation, they appeared to have different binding modes. They were both found to compete with eIF4A for BC200 RNA binding, possibly reflecting the ability of these hnRNPs to bind a broad region of BC200 RNA. However, only hnRNP E2 was able to form a ternary complex with BC200 RNA and eIF4A, and our footprinting analysis also showed that binding of hnRNP E1, but not hnRNP E2, induced a change in the secondary structure change in BC200 RNA. The differences in the binding modes of hnRNP E1 and E2 suggest that they may restore BC200 RNA-mediated translation inhibition via different mechanisms. Indeed, numerous reports have shown that hnRNP E1 and E2 have distinct actions, even though they share almost identical amino acid sequences [44] . For example, hnRNP E1 has a stronger affinity for AUF/hnRNP D than hnRNP E2 [44] , and the two proteins differ in their regulation of the hypoxic stress response of cortical neurons [45] .
With respect to other known BC200 RNA-binding proteins, the hnRNP E proteins and eIF4B [8] [9] [10] both bind BC200 RNA via its C-rich domain, and our present data further show that hnRNP E1 and E2 can compete for BC200 RNA binding with eIF4A, which binds to the A-rich domain. Therefore, hnRNP E1 and E2 may act by preventing components of the translational machinery, such as eIF4A and eIF4B, from binding to BC200 RNA. The underlying mechanism remains to be determined, however. hnRNP E1 and E2 participate in regulating mRNA stability, alternative splicing, transcription, and translation [21] [22] [23] , suggesting that the restoration of BC200 RNA-inhibited translation by these proteins could be linked to other cellular events. As BC200 RNA is highly expressed in cancer cells [46] [47] [48] , the identification of such linkages could critically improve our understanding of how BC200 RNA is involved in cancer metabolism. We recently found that only specific genes are down-regulated in BC200 RNA- 
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